Lack of health insurance coverage may affect hepatitis C patients' access to current antiviral treatments, according to a new study.

A study from South Korea has found a link between the Hepatitis A virus and patients with pre-existing chronic liver disease and identified the age group most at risk.

Scientists have created an antibody to remove the Hepatitis C virus from the bloodstream during liver transplant surgery in an effort to prevent re-infection of the organ, a problem that occurs in most cases.